Related Experiment Video

Updated: May 5, 2026

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
10:16

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions

Published on: June 28, 2018

33.1K

The American Heart Association's Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy

Andrea Beaton, Flavia B Kamalembo, James Dale

    Circulation
    |October 19, 2020
    PubMed

    Insights

    Rheumatic heart disease (RHD) impacts millions globally. The American Heart Association commits to RHD prevention and care through education, resources, research, and advocacy.

    Area of Science:

    • Cardiovascular Medicine
    • Global Health
    • Public Health Policy

    Background:

    • Rheumatic heart disease (RHD) is a significant global health burden, affecting approximately 40 million individuals and causing nearly 300,000 deaths annually.
    • A 2018 World Health Assembly resolution established a mandate for a coordinated global response to RHD.
    • The American Heart Association (AHA) aims to lead and support international efforts in RHD care and prevention.

    Purpose of the Study:

    • To outline the American Heart Association's commitment to combating Rheumatic Heart Disease.
    • To detail the key areas of focus for the AHA's global RHD control strategy.
    • To encourage collaborative efforts in RHD prevention and management.

    Main Methods:

    • The AHA pledges support across five critical areas: healthcare worker education, implementation of evidence-based prevention strategies, access to essential medical resources, research initiatives, and advocacy for increased global awareness and capacity.
    • This commitment is framed within the context of the global RHD response mandated by the World Health Assembly.

    Main Results:

    • The AHA's strategic commitment addresses multifaceted aspects of RHD control, from professional training to policy advocacy.
    • The outlined plan aims to bolster existing efforts and inspire broader engagement in the fight against RHD.

    Conclusions:

    • The American Heart Association is dedicated to leading and supporting global initiatives for Rheumatic Heart Disease prevention and care.
    • The AHA's comprehensive strategy, encompassing education, resources, research, and advocacy, seeks to inspire collaborative action to reduce the RHD burden worldwide.

    More Related Videos

    Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay13:51

    Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

    Published on: November 11, 2018

    10.2K
    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection08:15

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

    Published on: January 31, 2020

    8.9K

    Related Concept Videos

    Rheumatic Heart Disease I: Introduction01:23

    Rheumatic Heart Disease I: Introduction

    Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
    1.0K
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
    1.3K
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
    548
    Rheumatic Heart Disease IV: Nursing Management01:20

    Rheumatic Heart Disease IV: Nursing Management

    AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
    486
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    891
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    747